Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 11Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Uveal Melanoma 1Sarcoma 1Pancreatic Neoplasms 1Neurofibromatosis 2 1Myeloproliferative Disorders 1Multiple Myeloma 1Macular Degeneration 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 30Capecitabine 24Bevacizumab 23Cyclophosphamide 22Gemcitabine 21Paclitaxel 20Nivolumab 19Fluorouracil 19Docetaxel 18aldesleukin 17Leucovorin 17Irinotecan 17Oxaliplatin 15Interleukin-2 14Radiosurgery 13Cisplatin 13Cetuximab 13fludarabine 12Carboplatin 12Albumin-Bound Paclitaxel 11fludarabine phosphate 10Ipilimumab 10Drug Therapy 10Doxorubicin 10Sunitinib 9Radiotherapy 9Everolimus 9130-nm albumin-bound paclitaxel 9Trastuzumab 8Temozolomide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasm Metastasis × aflibercept × Clear all
NCT01669720 2020-02-17

C261

Brown University

Phase 2 Terminated
10 enrolled 7 charts
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

CR-CSSS Champlain-Charles-Le Moyne

Phase 2 Terminated
14 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡